Financial terms were not disclosed, although Nordion will leave an estimated US$18m in the company.
Best Medical has acquired all of MDS Nordion, with the exception of the TheraSphere business, which develops liver cancer therapeutics. 
The firm bought another Nordion company, Ottawa-based Theratronics, four years ago.
Nordion made a decision in the 2010 financial year to restructure or exit this business, stating that it wanted to reduce complexity, manage costs and focus on growing areas of the business.
The 55 employees at MDS Nordion will transfer to Best Medical, which will also acquire the Belgian production facilities. 
Nordion expects the transaction to be completed in the next few months.
                    
                
Nordion sells Belgian operation
Best Medical to buy MDS Nordion, terms not revealed
You may also like
                                                                            Finance
                                                
                            
                                
                            
                            
                Pfizer sues Metsera and Novo Nordisk over alleged breach of merger agreement
Read morePfizer has filed a lawsuit against Metsera, its Board of Directors and Novo Nordisk, alleging breach of contract, fiduciary duty and interference following Metsera’s decision to pursue a rival offer that Pfizer claims is “illegal”
                                
                        
                    Trending Articles
You may also like
                                                            Finance
                                                        
                                
                                                                            
                                                                    
                                
                    Pfizer sues Metsera and Novo Nordisk over alleged breach of merger agreement
Pfizer has filed a lawsuit against Metsera, its Board of Directors and Novo Nordisk, alleging breach of contract, fiduciary duty and interference following Metsera’s decision to pursue a rival offer that Pfizer claims is “illegal”
                                                                    
                                
                            
                        
                                                            Analysis
                                                        
                                
                                                                            
                                                                    
                                
                    Anton Paar UK launches trade-in programme: Save up to 30% on new instruments
Anton Paar Ltd, a global leader in high-precision laboratory and process instrumentation, has launched a limited-time trade-in programme offering customers in the UK up to 30% off the price of new instruments across its comprehensive product portfolio*
                                                                    
                                
                            
                        You need to be a subscriber to read this article.
                                            
Click here to find out more.
                                Click here to find out more.